Ginkgo Bioworks Holdings, Inc. (DNA)

Ginkgo Bioworks Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	203.57	561.57	944.07	1,316	1,550	380.8
Cash & Short-Term Investments	473.69	561.57	944.07	1,316	1,550	380.8
Cash Growth	-35.14%	-40.52%	-28.25%	-15.11%	307.04%	-23.11%
Accounts Receivable	23.13	22.44	17.9	82.47	136.14	21.91
Other Receivables	-	-	-	1.56	-	-
Receivables	23.13	22.44	30.19	84.03	147.7	24.17
Inventory	-	-	-	4.36	3.51	9.27
Prepaid Expenses	15.26	12.89	22.7	35.11	18.94	10.85
Restricted Cash	10.95	5.84	4.79	8.22	-	-
Other Current Assets	-	-	-	2.57	2.9	1.44
Total Current Assets	523.03	602.74	1,002	1,450	1,723	426.54
Property, Plant & Equipment	562.15	598.16	394.99	718.79	145.77	121.44
Long-Term Investments	32.66	48.7	78.57	113.73	115.23	103.12
Goodwill	-	-	49.24	60.21	21.31	1.86
Other Intangible Assets	66.15	72.51	82.74	111.04	21.64	3.29
Other Long-Term Assets	39.48	41.17	44.45	47.81	43.99	5.6
Total Assets	1,231	1,377	1,665	2,539	2,071	675.15
Accounts Payable	11.2	14.17	9.32	10.45	8.19	13.89
Accrued Expenses	51.79	19.19	49.87	52.3	85.14	17.73
Current Portion of Leases	-	28.97	17.47	29.33	0.75	0.49
Current Unearned Revenue	28.29	30.6	48.5	47.82	33.24	28.82
Other Current Liabilities	5.44	14.34	38.7	33.06	7.45	12.29
Total Current Liabilities	96.72	107.27	163.86	172.96	134.76	73.22
Long-Term Leases	428.83	438.79	221.84	413.26	22.28	16.52
Long-Term Unearned Revenue	74.57	98.78	158.06	174.77	155.99	99.65
Other Long-Term Liabilities	17.94	16.55	24.43	42.06	190.58	15.71
Total Liabilities	618.06	661.39	568.19	803.04	503.61	205.1
Common Stock	0.01	0.01	0.01	0.19	0.16	0.13
Additional Paid-In Capital	6,600	6,555	6,386	6,136	3,805	929.13
Retained Earnings	-5,989	-5,838	-5,291	-4,398	-2,298	-467.88
Comprehensive Income & Other	1.65	-1.81	1.48	-2.63	-1.72	-
Total Common Equity	612.95	716.06	1,097	1,736	1,505	461.38
Minority Interest	-	-	-	-	62.01	8.68
Shareholders' Equity	612.95	716.06	1,097	1,736	1,567	470.05
Total Liabilities & Equity	1,231	1,377	1,665	2,539	2,071	675.15
Total Debt	428.83	467.76	239.31	442.59	23.03	17
Net Cash (Debt)	44.86	93.82	704.76	873.2	1,527	363.8
Net Cash Growth	-83.87%	-86.69%	-19.29%	-42.81%	319.73%	-23.88%
Net Cash Per Share	0.83	1.81	14.50	20.79	44.90	11.42
Filing Date Shares Outstanding	55.43	54.37	50.03	51.81	43.99	7.85
Total Common Shares Outstanding	55.43	54.37	50.03	47.3	40.28	7.85
Working Capital	426.31	495.48	837.89	1,277	1,588	353.32
Book Value Per Share	11.06	13.17	21.93	36.71	37.37	58.77
Tangible Book Value	546.8	643.55	965.17	1,565	1,462	456.23
Tangible Book Value Per Share	9.87	11.84	19.29	33.09	36.30	58.11
Land	6.06	6.06	6.06	6.06	-	-
Buildings	49.76	48.26	47.03	-	-	-
Machinery	163.58	172.33	168.42	206.72	128.75	56.14
Construction In Progress	-	1.98	15.83	23.43	10.28	42.58
Leasehold Improvements	140.45	135.96	71.56	125.31	55.03	40.44

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q